Appraisal of A&bgr;PP Transgenic Mice as Models for Alzheimer's Disease Amyloid Cascade

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 1, 2003-03 ,pp. : 85-90

Bentham Science Publishers

Access to resources Recommend Favorite

A&bgr; Metallobiology and the Development of Novel Metal-Protein Attenuating Compounds (MPACs) for Alzheimer's Disease

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 4, 2003-12 ,pp. : 309-315

Bentham Science Publishers

Access to resources Recommend Favorite

Immunotoxin Lesion of the Cholinergic Nucleus Basalis Causes A&bgr; Deposition: Towards a Physiologic Animal Model of Alzheimer's Disease

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 3, Iss. 1, 2003-01 ,pp. : 57-75

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid -peptide

By Butterfield D.A.   Drake J.   Pocernich C.   Castegna A.  

Trends in Molecular Medicine, Vol. 7, Iss. 12, 2001-12 ,pp. : 548-554

Elsevier

Access to resources Recommend Favorite

The Role of Endocytic Pathways on Estrogen Receptor α Intracellular Trafficking and 17&bgr;-estradiol Signaling

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 14, Iss. 2, 2014-08 ,pp. : 75-90

Bentham Science Publishers

Access to resources Recommend Favorite